Consider Praxbind to Reverse Pradaxa In Patients with Life-Threatening Bleeding

Praxbind (PRAKS-bynd, idarucizumab) will be the first reversal agent for ONE of the direct oral anticoagulants.

Praxbind is an IV monoclonal antibody fragment that binds to the thrombin inhibitor, Pradaxa (dabigatran), to reverse anticoagulation.

But Praxbind won't work for factor Xa inhibitors...Xarelto (rivaroxaban), Eliquis (apixaban), or Savaysa (edoxaban).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote